Genesys Biologics Is A Biosimilar Company Founded In November 2014 And Based In Hyderabadindiathe Company Focuses On Developing High Qualitysafeand Affordable Insulin Biosimilars To Improve Access For Diabetes Patients Globallygenesys Biologics Aims To Become A Leading Player In The Biopharmaceutical Industry The Company Specializes In The Developmentscale Uptechnology Transferand Manufacturing Of Biosimilarsit Collaborates With Other Organizations For Commercialization And Supply Chain Managementstreamlining The Process For Delivering Insulin To Patientsone Of Its Key Products Is A Biosimilar Version Of Insulin Glarginewhich Is Currently Progressing Through Clinical Trials Genesys Biologics Operates A Research And Development Facility In Genome Valleyhyderabadand Is Developing A Commercial Manufacturing Plant In Telangana With Support From The U Sdevelopment Finance Corporationthe Company Is On Track To Complete Its Clinical Trials By February 2024 And Plans To Begin Commercial Operations By June 2024Aiming To Enhance Access To Insulin For Diabetic Patients Worldwide
